Mantle Cell Lymphoma Life Expectancy Depends On Various Factors

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of non-Hodgkin's lymphoma, and it generally does not have a good prognosis. It is a very rare disease, affecting no more than about 4,000 people (generally men and generally older than 60) in the US every year. This is the equivalent of about 5% of all non-Hodgkin's lymphoma diagnoses made annually.

Mantle cell lymphoma is poorly understood by the medical community, largely because it was only recognized as a legitimately unique B-cell NHL subtype twenty years ago. In that time, a wide variety of treatments—including chemotherapy, radiotherapy, stem cell transplantations, and immunotherapy—have been applied to patients with mantle cell lymphoma, with varying results, none of them especially convincing or leading to much enthusiasm in the research community.

Life Expectancy

The life expectancy for any patient receiving a diagnosis of mantle cell lymphoma will vary widely, depending on various factors ranging from age and health status, to stage of the disease at diagnosis and whether the patient has so-called B symptoms or not. The problem is that in many instances, and following virtually all modes of treatment, the disease is extremely prone to returning; relapse in is very common, and when relapse occurs, the relapsed disease has all too commonly become chemo-resistant as well.

Thus, while it is impossible to say how long any one individual patient will survive following a diagnosis of mantle cell lmyphoma, currently the life expectancy is cited as being in the range of four to five years following diagosis, according to researchers at the John Theurer Cancer Center in Hackensack, New Jersey.

Sources

Related Reading

Photo: Pexels

More Articles

More Articles

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

Is there such a thing as an average cost of chemotherapy? No. Not even close. In order for there to be an average cost of chemotherapy, one would...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

This entry looks at one of those types of lymphoma sometimes referred to simply as abdominal lymphoma. 'Lymphoma' is an umbrella term that...

Usually, even if a subtype of lymphoma is known to be indolent (slow-growing), it is considered a malignant...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Hodgkin's Lymphoma a.k.a. Hodgkin's Disease is a malignant (cancerous) growth of cells in the lymphatic system...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...